Cambridge Investment Research Advisors Inc. lowered its holdings in shares of Monsanto Company (NYSE:MON) by 21.1% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 11,568 shares of the basic materials company’s stock after selling 3,101 shares during the period. Cambridge Investment Research Advisors Inc.’s holdings in Monsanto were worth $1,386,000 as of its most recent filing with the SEC.

Several other hedge funds have also added to or reduced their stakes in the stock. Stratos Wealth Partners LTD. grew its holdings in shares of Monsanto by 20.1% during the 3rd quarter. Stratos Wealth Partners LTD. now owns 4,803 shares of the basic materials company’s stock valued at $576,000 after purchasing an additional 805 shares during the last quarter. Kwmg LLC grew its holdings in shares of Monsanto by 6.2% during the 3rd quarter. Kwmg LLC now owns 13,951 shares of the basic materials company’s stock valued at $1,672,000 after purchasing an additional 813 shares during the last quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund grew its holdings in shares of Monsanto by 4.8% during the 3rd quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 108,871 shares of the basic materials company’s stock valued at $13,045,000 after purchasing an additional 5,024 shares during the last quarter. Signature Estate & Investment Advisors LLC grew its holdings in shares of Monsanto by 4.0% during the 3rd quarter. Signature Estate & Investment Advisors LLC now owns 138,242 shares of the basic materials company’s stock valued at $16,564,000 after purchasing an additional 5,292 shares during the last quarter. Finally, Teacher Retirement System of Texas grew its holdings in shares of Monsanto by 0.6% during the 3rd quarter. Teacher Retirement System of Texas now owns 229,878 shares of the basic materials company’s stock valued at $27,544,000 after purchasing an additional 1,363 shares during the last quarter. 74.98% of the stock is currently owned by institutional investors.

Several equities analysts recently commented on the stock. Royal Bank Of Canada reaffirmed a “hold” rating and set a $128.00 target price on shares of Monsanto in a report on Wednesday, November 15th. Wells Fargo & Company increased their target price on shares of Monsanto from $107.50 to $118.00 and gave the company a “market perform” rating in a report on Tuesday, October 10th. Barclays PLC reaffirmed an “equal weight” rating and set a $124.00 target price (up previously from $120.00) on shares of Monsanto in a report on Thursday, October 5th. BMO Capital Markets reaffirmed a “buy” rating and set a $128.00 target price on shares of Monsanto in a report on Thursday, October 5th. Finally, Macquarie lowered shares of Monsanto from an “outperform” rating to a “neutral” rating in a report on Wednesday, October 4th. Eleven investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The company has an average rating of “Hold” and an average target price of $124.61.

ILLEGAL ACTIVITY NOTICE: “Cambridge Investment Research Advisors Inc. Sells 3,101 Shares of Monsanto Company (MON)” was first reported by Watch List News and is the sole property of of Watch List News. If you are viewing this news story on another publication, it was stolen and reposted in violation of U.S. & international copyright & trademark legislation. The legal version of this news story can be read at https://www.watchlistnews.com/cambridge-investment-research-advisors-inc-sells-3101-shares-of-monsanto-company-mon/1717742.html.

Monsanto Company (NYSE MON) traded down $0.24 during trading hours on Tuesday, hitting $118.09. 1,329,200 shares of the stock traded hands, compared to its average volume of 1,936,123. Monsanto Company has a 12-month low of $100.87 and a 12-month high of $122.79. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.83 and a current ratio of 1.35. The stock has a market cap of $52,088.87, a PE ratio of 21.40, a price-to-earnings-growth ratio of 1.70 and a beta of 1.05.

Monsanto (NYSE:MON) last posted its earnings results on Wednesday, October 4th. The basic materials company reported $0.20 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.41) by $0.61. Monsanto had a net margin of 15.44% and a return on equity of 42.40%. The firm had revenue of $2.69 billion during the quarter, compared to analysts’ expectations of $2.51 billion. During the same period last year, the company posted $0.07 EPS. The company’s quarterly revenue was up 4.8% compared to the same quarter last year. equities research analysts expect that Monsanto Company will post 5.74 earnings per share for the current fiscal year.

In related news, COO Brett D. Begemann sold 22,640 shares of Monsanto stock in a transaction dated Monday, September 25th. The shares were sold at an average price of $120.03, for a total transaction of $2,717,479.20. Following the completion of the transaction, the chief operating officer now directly owns 85,439 shares of the company’s stock, valued at approximately $10,255,243.17. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CFO Pierre Courduroux sold 4,320 shares of Monsanto stock in a transaction dated Thursday, October 19th. The shares were sold at an average price of $122.00, for a total transaction of $527,040.00. Following the transaction, the chief financial officer now directly owns 48,388 shares of the company’s stock, valued at $5,903,336. The disclosure for this sale can be found here. Over the last three months, insiders have sold 49,236 shares of company stock valued at $5,931,934. 0.79% of the stock is currently owned by corporate insiders.

About Monsanto

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with Analyst Ratings Network's FREE daily email newsletter.